edelfosine has been researched along with Carcinoma, Anaplastic in 3 studies
edelfosine: RN given refers to parent cpd
edelfosine : A racemate comprising equimolar amounts of (R)- and (S)-edelfosine.
1-octadecyl-2-methylglycero-3-phosphocholine : A glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steinestel, K | 1 |
| Eder, S | 1 |
| Ehinger, K | 1 |
| Schneider, J | 1 |
| Genze, F | 1 |
| Winkler, E | 1 |
| Wardelmann, E | 1 |
| Schrader, AJ | 1 |
| Steinestel, J | 1 |
| Maistry, L | 1 |
| Robinson, KM | 1 |
| Evers, P | 1 |
| Munder, PG | 1 |
| Andreesen, R | 1 |
| Berdel, WE | 1 |
| Fink, U | 1 |
| Rastetter, J | 1 |
1 trial available for edelfosine and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Clinical phase I pilot study of the alkyl lysophospholipid derivative ET-18-OCH3.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma; | 1987 |
2 other studies available for edelfosine and Carcinoma, Anaplastic
| Article | Year |
|---|---|
The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells.
Topics: Adult; Aged; Calcium; Carcinoma; Cell Movement; Female; Gene Expression Regulation, Neoplastic; Huma | 2016 |
Morphological effects of an antitumor agent on human esophageal carcinoma cells in vitro.
Topics: Carcinoma; Cell Line; Cell Membrane; Drug Evaluation, Preclinical; Esophageal Neoplasms; Humans; Lys | 1980 |